EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Weigh up your evidence carefully before reaching a conclusion. Evaluating the #skin #sensitisation potential of a squaric a…
Edelweiss Connect (2 weeks ago)
Integrated Approaches to solving Skin Safety Assessment problems #skinsafety #skincare #cosmetics #invitro… https://t.co/oUvJ1xByGf
Edelweiss Connect (4 weeks ago)
RT @sysrev1: ICYMI: Here is the full webinar - presented by #SaferWorldByDesign. https://t.co/PeeKfmRsk2 Founder @tomlue discusses #Sysrev…
Edelweiss Connect (4 weeks ago)
RT @LabsExplorer: New workflow to collect, analyse and report on #nanomaterials characterisation data from @edelweissconn. Find more about…
Edelweiss Connect (5 weeks ago)
RT @sysrev1: #Webinar by #SaferWorldByDesign: Sysrev - a collaborative platform for data extraction. March 3, 2020 @ 16:00 CET | 10:00 EST…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA